Roflumilast Cream 0.3%

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Roflumilast Cream 0.3% for Moderate to Severe Atopic DermatitisNCT07916480ARQTPhase 3Recruiting2028-04-27Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.